Work

FV 3 Analysis of cerebrospinal fluid (CSF) biomarkers to predict risk of clinical decline and progression to dementia in patients with mild cognitive impairment and mild cognitive symptoms

Year: 2019

Type: article

Source: Clinical Neurophysiology

DOI: 10.1016/j.clinph.2019.04.613

Authors: L.M. Shaw, V. Corradini, K. Blennow, K. Buck, U. Eichenlaub, V. Lifke, M. Widmann, M. Simon, O. Hansson

Institutions: University of Pennsylvania, Roche (Switzerland), Roche Diagnostics International AG (Switzerland), Sahlgrenska University Hospital, University of Gothenburg, Lund University, Skåne University Hospital

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2954048176

FWCI:

Cites:

Cited by:

Related to: 10